Equine Pharmaceuticals and Supplements Market

Chapter 1 Equine Pharmaceuticals and Supplements Market Overview

1.1 Equine Pharmaceuticals and Supplements Definition

1.2 Global Equine Pharmaceuticals and Supplements Market Size Status and Outlook (2019-2032)

1.3 Global Equine Pharmaceuticals and Supplements Market Size Comparison by Region (2019-2032)

1.4 Global Equine Pharmaceuticals and Supplements Market Size Comparison by Type (2019-2032)

1.5 Global Equine Pharmaceuticals and Supplements Market Size Comparison by Application (2019-2032)

1.6 Global Equine Pharmaceuticals and Supplements Market Size Comparison by Sales Channel (2019-2032)

1.7 Equine Pharmaceuticals and Supplements Market Dynamics

1.7.1 Market Drivers/Opportunities

1.7.2 Market Challenges/Risks

1.7.3 Market News (Products Launch, Mergers, Acquisitions, Expansion, Agreement and Collaborations, Partnerships)

1.7.4 COVID-19 Impacts

1.7.5 Russia-Ukraine War Impacts

1.7.6 US-Israel-Iran War Impacts

Chapter 2 Executive Summary

2.1 Global Equine Pharmaceuticals and Supplements Market Snapshot

2.2 Global Equine Pharmaceuticals and Supplements Market Volume & Revenue 2019-2025

2.3 Global Equine Pharmaceuticals and Supplements Market Differential Growth Potential Analysis by Type, 2019-2032 (USD Million)

2.4 Global Equine Pharmaceuticals and Supplements Market Differential Growth Potential Analysis by Application, 2019-2032 (USD Million)

2.5 Global Equine Pharmaceuticals and Supplements Market Differential Growth Potential Analysis by Sales Channels, 2019-2032 (USD Million)

2.6 Global Equine Pharmaceuticals and Supplements Market Differential Growth Potential Analysis by Region, 2019-2032 (USD Million)

Chapter 3 Equine Pharmaceuticals and Supplements Market Segment Analysis by Player

3.1 Global Equine Pharmaceuticals and Supplements Sales and Market Share by Player (2023-2025)

3.2 Global Equine Pharmaceuticals and Supplements Revenue and Market Share by Player (2023-2025)

3.3 Global Equine Pharmaceuticals and Supplements Average Price by Player (2023-2025)

3.4 Players Competition Situation & Trends (2023-2025)

3.5 Conclusion of Segment by Player

Chapter 4 Equine Pharmaceuticals and Supplements Market Segment Analysis by Type

4.1 Global Equine Pharmaceuticals and Supplements Market by Type

4.1.1 Pharmaceuticals

4.1.2 Supplements

4.2 Global Equine Pharmaceuticals and Supplements Sales and Market Share by Type (2019-2025)

4.3 Global Equine Pharmaceuticals and Supplements Revenue and Market Share by Type (2019-2025)

4.4 Global Equine Pharmaceuticals and Supplements Average Price by Type (2019-2025)

4.5 Leading Players of Equine Pharmaceuticals and Supplements by Type in 2025

4.6 Conclusion of Segment by Type

Chapter 5 Equine Pharmaceuticals and Supplements Market Segment Analysis by Application

5.1 Global Equine Pharmaceuticals and Supplements Market by Application

5.1.1 Thoroughbred Horse

5.1.2 Other Types of Horses

5.2 Global Equine Pharmaceuticals and Supplements Revenue and Market Share by Application (2019-2025)

5.3 Leading Consumers of Equine Pharmaceuticals and Supplements by Application in 2025

5.4 Conclusion of Segment by Application

Chapter 6 Equine Pharmaceuticals and Supplements Market Segment Analysis by Sales Channel

6.1 Global Equine Pharmaceuticals and Supplements Market by Sales Channel

6.1.1 Global Equine Pharmaceuticals and Supplements Market, by Direct Channel Market Analysis 2019-2032 (USD Million)

6.1.2 Global Equine Pharmaceuticals and Supplements Market, by Distribution Channel Market Analysis 2019-2032 (USD Million)

6.2 Global Equine Pharmaceuticals and Supplements Revenue and Market Share by Sales Channel (2019-2025)

6.3 Leading Distributors/Dealers of Equine Pharmaceuticals and Supplements by Sales Channel in 2025

6.4 Conclusion of Segment by Sales Channel

Chapter 7 Equine Pharmaceuticals and Supplements Market Segment Analysis by Region

7.1 Global Equine Pharmaceuticals and Supplements Market Size and CAGR by Region (2019-2032)

7.2 Global Equine Pharmaceuticals and Supplements Sales and Market Share by Region (2019-2025)

7.3 Global Equine Pharmaceuticals and Supplements Revenue and Market Share by Region (2019-2025)

7.4 North America

7.4.1 North America Market by Country

7.4.2 North America Equine Pharmaceuticals and Supplements Market Share by Type

7.4.3 North America Equine Pharmaceuticals and Supplements Market Share by Application

7.4.4 United States

7.4.5 Canada

7.4.6 Mexico

7.5 Europe

7.5.1 Europe Market by Country

7.5.2 Europe Equine Pharmaceuticals and Supplements Market Share by Type

7.5.3 Europe Equine Pharmaceuticals and Supplements Market Share by Application

7.5.4 Germany

7.5.5 United Kingdom

7.5.6 France

7.5.7 Italy

7.5.8 Russia

7.5.9 Spain

7.5.10 Benelux

7.5.11 Poland

7.5.12 Austria

7.5.13 Portugal

7.5.14 Rest of Europe

7.6 Asia-Pacific

7.6.1 Asia-Pacific Market by Country

7.6.2 Asia-Pacific Equine Pharmaceuticals and Supplements Market Share by Type

7.6.3 Asia-Pacific Equine Pharmaceuticals and Supplements Market Share by Application

7.6.4 China

7.6.5 Japan

7.6.6 Korea

7.6.7 India

7.6.8 Southeast Asia

7.6.9 Australia

7.6.10 Taiwan

7.6.11 Rest of Asia Pacific

7.7 South America

7.7.1 South America Market by Country

7.7.2 South America Equine Pharmaceuticals and Supplements Market Share by Type

7.7.3 South America Equine Pharmaceuticals and Supplements Market Share by Application

7.7.4 Brazil

7.7.5 Argentina

7.7.6 Colombia

7.7.7 Chile

7.7.8 Peru

7.7.9 Venezuela

7.7.10 Rest of South America

7.8 Middle East & Africa

7.8.1 Middle East & Africa Market by Country

7.8.2 Middle East & Africa Equine Pharmaceuticals and Supplements Market Share by Type

7.8.3 Middle East & Africa Equine Pharmaceuticals and Supplements Market Share by Application

7.8.4 UAE

7.8.5 Saudi Arabia

7.8.6 South Africa

7.8.7 Egypt

7.8.8 Nigeria

7.8.9 Rest of Middle East & Africa

7.9 Conclusion of Segment by Region

Chapter 8 Profile of Leading Equine Pharmaceuticals and Supplements Players

8.1 Boehringer Ingelheim

8.1.1 Company Snapshot

8.1.2 Product/Service Offered

8.1.3 Business Performance (Sales, Price, Revenue, Gross Margin and Market Share)

8.1.4 Recent Developments

8.2 Merck Animal Health

8.2.1 Company Snapshot

8.2.2 Product/Service Offered

8.2.3 Business Performance (Sales, Price, Revenue, Gross Margin and Market Share)

8.2.4 Recent Developments

8.3 Zoetis

8.3.1 Company Snapshot

8.3.2 Product/Service Offered

8.3.3 Business Performance (Sales, Price, Revenue, Gross Margin and Market Share)

8.3.4 Recent Developments

8.4 Bayer Animal Health

8.4.1 Company Snapshot

8.4.2 Product/Service Offered

8.4.3 Business Performance (Sales, Price, Revenue, Gross Margin and Market Share)

8.4.4 Recent Developments

8.5 Elanco Animal Health

8.5.1 Company Snapshot

8.5.2 Product/Service Offered

8.5.3 Business Performance (Sales, Price, Revenue, Gross Margin and Market Share)

8.5.4 Recent Developments

8.6 Dechra Veterinary Products

8.6.1 Company Snapshot

8.6.2 Product/Service Offered

8.6.3 Business Performance (Sales, Price, Revenue, Gross Margin and Market Share)

8.6.4 Recent Developments

8.7 CEVA

8.7.1 Company Snapshot

8.7.2 Product/Service Offered

8.7.3 Business Performance (Sales, Price, Revenue, Gross Margin and Market Share)

8.7.4 Recent Developments

8.8 Virbac

8.8.1 Company Snapshot

8.8.2 Product/Service Offered

8.8.3 Business Performance (Sales, Price, Revenue, Gross Margin and Market Share)

8.8.4 Recent Developments

8.9 Norbrook Equine

8.9.1 Company Snapshot

8.9.2 Product/Service Offered

8.9.3 Business Performance (Sales, Price, Revenue, Gross Margin and Market Share)

8.9.4 Recent Developments

8.10 Kyoritsu Seiyaku

8.10.1 Company Snapshot

8.10.2 Product/Service Offered

8.10.3 Business Performance (Sales, Price, Revenue, Gross Margin and Market Share)

8.10.4 Recent Developments

8.11 Vetoquinol

8.11.1 Company Snapshot

8.11.2 Product/Service Offered

8.11.3 Business Performance (Sales, Price, Revenue, Gross Margin and Market Share)

8.11.4 Recent Developments

8.12 Protexin Healthcare

8.12.1 Company Snapshot

8.12.2 Product/Service Offered

8.12.3 Business Performance (Sales, Price, Revenue, Gross Margin and Market Share)

8.12.4 Recent Developments

8.13 Audevard

8.13.1 Company Snapshot

8.13.2 Product/Service Offered

8.13.3 Business Performance (Sales, Price, Revenue, Gross Margin and Market Share)

8.13.4 Recent Developments

8.14 Ouro Fino Saude

8.14.1 Company Snapshot

8.14.2 Product/Service Offered

8.14.3 Business Performance (Sales, Price, Revenue, Gross Margin and Market Share)

8.14.4 Recent Developments

Chapter 9 Upstream and Downstream Analysis of Equine Pharmaceuticals and Supplements

9.1 Industrial Chain of Equine Pharmaceuticals and Supplements

9.2 Upstream of Equine Pharmaceuticals and Supplements

9.2.1 Raw Materials (If Applicable)

9.2.2 Manufacturing Cost Structure (If Applicable)

9.2.3 Manufacturing Process (If Applicable)

9.3 Downstream of Equine Pharmaceuticals and Supplements

9.3.1 Leading Distributors/Dealers of Equine Pharmaceuticals and Supplements

9.3.2 Leading Consumers of Equine Pharmaceuticals and Supplements

Chapter 10. Global Equine Pharmaceuticals and Supplements Market Industry Analysis

10.1. Porter's Five Forces Analysis

10.1.1. Threat of New Entrants

10.1.2. Bargaining Power of Buyers/Consumers

10.1.3. Bargaining Power of Suppliers

10.1.4. Threat of Substitute Types

10.1.5. Intensity of Competitive Rivalry

10.2. Major Growth Avenues within Global Equine Pharmaceuticals and Supplements Market

10.2.1. Product Types

10.2.2. Applications

10.2.3. Sales Channels

10.2.4. Country

10.3. Equine Pharmaceuticals and Supplements Industry Ecosystem

10.4. Price Trend Analysis (If Applicable)

10.5. Buying Criteria (If Applicable)

10.6. Regulations (If Applicable)

Chapter 11 Development Trend of Equine Pharmaceuticals and Supplements (2026-2032)

11.1 Global Equine Pharmaceuticals and Supplements Market Size (Sales and Revenue) Forecast (2026-2032)

11.2 Global Equine Pharmaceuticals and Supplements Market Size and CAGR Forecast by Region (2026-2032)

11.3 Global Equine Pharmaceuticals and Supplements Market Size and CAGR Forecast by Type (2026-2032)

11.4 Global Equine Pharmaceuticals and Supplements Market Size and CAGR Forecast by Application (2026-2032)

11.5 Global Equine Pharmaceuticals and Supplements Market Size and CAGR Forecast by Sales Channel (2026-2032)

Chapter 12. Import - Export Analysis (If Applicable)

12.1 North America Equine Pharmaceuticals and Supplements Import-Export, 2019-2025

12.2 Europe Equine Pharmaceuticals and Supplements Import-Export, 2019-2025

12.3 Asia Pacific Equine Pharmaceuticals and Supplements Import-Export, 2019-2025

12.4 South America Equine Pharmaceuticals and Supplements Import-Export, 2019-2025

12.5 Middle East & Africa Equine Pharmaceuticals and Supplements Import-Export, 2019-2025

Chapter 13. Demand-Supply Gap Analysis (If Applicable)

13.1 North America Equine Pharmaceuticals and Supplements Demand-Supply, 2019-2025

13.2 Europe Equine Pharmaceuticals and Supplements Demand-Supply, 2019-2025

13.3 Asia Pacific Equine Pharmaceuticals and Supplements Demand-Supply, 2019-2025

13.4 South America Equine Pharmaceuticals and Supplements Demand-Supply, 2019-2025

13.5 Middle East & Africa Equine Pharmaceuticals and Supplements Demand-Supply, 2019-2025

Chapter 14 Appendix

14.1 Research Methodology

14.2 Data Sources